Work

CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib via inhibiting AKT pathway

Year: 2021

Type: article

Source: Chemico-Biological Interactions

DOI: 10.1016/j.cbi.2021.109747

Authors: ShiLong Jiang, Ting Jiang, HanXue Huang, XiSha Chen, LanYa Li, ZhiBin Wang, JiangFeng Fei, Chong Liu, ZhaoQian Liu, Yan Cheng

Institutions: Central South University, Xiangya Hospital Central South University, Second Xiangya Hospital of Central South University

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Natural Science Foundation of China

OpenAlex ID: W3216096944

FWCI: 0.314

Cites: 42

Cited by: 11

Related to: 10